Patent · US Active

Using nucleosome interacting protein domains to enhance targeted genome modification

US10604752B2 · kind B2 · utility

5Cited by

0References

22Claims

0Family size

Assignee

Sigma-Aldrich Co. LLC · US

Inventors

Fuqiang Chen · Chesterfield, US
Xiao Ding · Chesterfield, US
Yongmei Feng · Village of La Jolla, US
Gregory D. Davis · Berkeley, US

Key dates

Filing date	Jul 10, 2018
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Jul 10, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.